Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

Cost of Revenue

$719.42M

TTM · Period ending: Jun 30, 2026 · USD

BCRX Cost of Revenue

Latest reported$719.42Mperiod endingJun 30, 2026

Latest reported$719.42Mperiod endingJun 30, 2026

BCRX TTM Cost of Revenue ($5.00M → $719.42M)

TTM cost of revenue

High-resolution chart · PNG

BCRX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	323,780
Mar 31, 2001	154,780
Dec 31, 2000	0
Sep 30, 2000	-607,780
Jun 30, 2000	-523,780
Mar 31, 2000	-554,780
Dec 31, 1999	-500,000
Sep 30, 1999	-500,000
Jun 30, 1999	-500,000
Mar 31, 1999	-600,000
Dec 31, 1998	-600,000
Sep 30, 1998	-600,000
Jun 30, 1998	-700,000
Mar 31, 1998	-600,000
Dec 31, 1997	-600,000
Sep 30, 1997	7,000,000
Jun 30, 1997	7,100,000
Mar 31, 1997	7,100,000
Dec 31, 1996	7,100,000
Sep 30, 1996	6,500,000
Jun 30, 1996	6,500,000
Mar 31, 1996	6,600,000
Dec 31, 1995	6,500,000
Sep 30, 1995	1,200,000
Jun 30, 1995	2,600,000
Mar 31, 1995	3,900,000
Dec 31, 1994	5,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.